cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25934/00006350
title: Early intervention with anti-inflammatory treatment of childhood bronchial asthma. A comparison between budesonide and disodium cromoglycate.


description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006428
title: A phase II study of ZD1839 (Iressa) and tamoxifen in patients with epithelial ovarian carcinoma cancer of the fallopian tube or the peritnoneum refractroy to platinum and taxane based therapy

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006430
title: An Open-label, Single-Centre Study to Assess the Intra-Subject Variability of the Pharmacokinetics of ZD1839 after Single Oral Doses of the 250 mg Tablet in Healthy Male Subjects (1839IL/0208).


description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006431
title: An open label study to investigate the effect of the jejunal pH environment on the precipitation and pharmacokinetics of a single oral dose of 250 mg ZD1839 in healthy male volunteers using the Loc-I-Gut technique

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006432
title: An open-label, multi-centre, parallel group, phase 1 study to compare the pharmacokinetics of ZD1839 (IRESSA TM) 250mg in patients with hepatic impairment and healthy volunteers.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006433
title: An open label multicentre Phase II non comparative trial of ZD1839 monotherapy in chemotherapy naiive patients with Stage IV or Stage III non operable non small cell lung carcinoma

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006353
title: Safety and efficacy of fluticasone propionate via Diskhaler and budesonide via Turbuhaler in a dose reduction study in asthmatic patients starting at daily doses of 1500 �g and 1600 �g, respectively.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006351
title: Double-blind, randomized, placebo-controlled, comparative investigation of the airway anti-inflammatory effects of budesonide and nedocromil sodium in adult asthmatic patients initiated on regular prophylactic medication

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006435
title: A Pilot Trial Of Escalating Doses Of Oral ZD1839 (Iressa) In Combination With Docetaxel And Estramustine In Patients With Hormone Refractory Prostate Cancer.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006354
title: One year open follow-up to study;Effect of one year treatment with budesonide Turbuhaler and nedocromil pMDI with spacer on bone mineral density,physical activity,and lung function in nwely diagnosed asthmatic children

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006337
title: An Open, Non-Randomised, Multi-Centre, Phase I, Study To Compare The Pharmacokinetics And Tolerability Of Multiple Oral Doses Of ZD1839 (IRESSA) In Patients With Solid Tumours And Normal, Moderate Or Severe Hepatic Impairment.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006438
title: An open-label, randomized crossover study of budesonide pharmacokinetics and the effect of budesonide on 24-hour plasma/urine cortisol concentrations when administered via HFA pMDI, CFC pMDI and Turbuhaler for 6.5 days in healthy volunteers

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006357
title: Budecort Suspension in the Treatment of Acute Asthma in Children Consulting the Emergency Room

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006439
title: EUROSCOP-European Respiratory Society study on Chronic Obstructive Pulmonary Disease.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006442
title: Pharmacokinetics and systemic effects after single and repeated dosing of fluticasone propionate from Diskus and pMDi and of budesonide from Turbuhaler in healthy volunteers.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006443
title: Efficacy and safety of Pulmicort (budesonide) via Turbuhaler, new version, in corticosteroid-using adult asthmatic patients

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006313
title: A safety and efficacy study of two dosage levels of Pulmicort Respules (budesonide inhalation suspension 0.5 or 1.0 mg/day) versus placebo in infants between the age of six and twelve months with mild to moderate asthma.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006314
title: An evaluation of Pulmicort� Respules (budesonide nebulizing suspension) versus Intal� (cromolyn sodium) Nebulizer Solution on asthma-related outcomes in children two to six years old. (USA titel: DX-RES-2000)

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006315
title: A double-blind, randomized, placebo-controlled study to determine the efficacy, maintenance effect and safety of 200 �g and 400 �g Pulmicort� (budesonide) Turbuhaler� given once daily to adults with mild-to-moderate asthma

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006317
title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Pulmicort (budesonide) Turbuhaler 400 mcg Administered Once Daily for 12 Weeks, in Adult Patients with Nonsteroid-Dependent Asthma.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006320
title: A Single-center, Sodium and Potassium Excretion Study of Healthy Subjects Administered ZS-9

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006312
title: A Three-Year Open-Label Safety Study of Budesonide (Pulmicort) Nebulizing Suspension in Asthmatic Children

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006415
title: An Open-Label,  Phase I Study to Compare the Pharmacokinetics of a Single, Short-Acting Intramuscular Dose of Fulvestrant (FASLODEXTM) (18 mg) in Subjects with Hepatic Impairment and in Healthy Control Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006417
title: An Open, Phase I, Rising Multiple-Dose Tolerability Trial of ZD1839 in Patients with Solid, Malignant Tumors

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006418
title: A Phase I/IIA Exploratory Multiple-Dose Level Pharmacokinetic And Pharmacodynamic Trial Of ZD1839 In Subjects With 4 Selected Tumour Types Known To Over-Express Epidermal Growth Factor Receptor (EGFR).

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006305
title: A Phase I/IIa Exploratory Multiple-dose Level Pharmacokinetic and harmacodynamic Trial of ZD1839 in Subjects With 5 Selected Tumor Types Known to Over-express Epidermal Growth Factor Receptor (EGFR) 


description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006307
title: A Randomized, Double Blind, Parallel Group, Phase II/III, Multi-center Trial of Two Doses of ZD1839 (IressaTM) in Patients with Advanced NSCLC Who Have Failed at Least Two Previous Chemotherapy Regimens At Least One or Both Having Contained Platinum and a Taxane.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006308
title: A Study to Assess the Metabolism and Excretion of a Single Oral Solution Dose of 250 mg [14C]- ZD1839 in Healthy Male and Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006309
title: A Randomised, Open-label, Single-centre, Crossover Study in Healthy Male Subjects to Compare the Pharmacokinetics of ZD1839 (Iressa�) 250 mg Administered as a Granular Formulation and the Sales Tablet.

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006990
title: An open label, noncompararive, multicenter phase II trial to assess the efficacy and safety of ZD1839 250mg for the treatment of non-small cell lung cancer patients who have failed previous chemotherapy

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00007010
title: A phase II study to evaluate ZD1839 (Iressa) in second line combination with paclitaxel (taxol) and carboplatin (paraplatin) in patients with advanced ovarian, peritoneal or fallopian tube adenocarcinoma

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00006959
title: Protective effect of high dose inhaled budesonide on cough induced by citric acid

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00007017
title: A randomized, controlled, multi-centre trial to determine the effects of doubling the dose of inhaled budesonide during exacerbation in asthmatics

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.